Angiodynamics (ANGO) Current Assets (2011 - 2026)

Angiodynamics has reported Current Assets for 16 years, with the latest figure at $155.6 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 9.71% year-over-year to $155.6 million; the trailing twelve-month figure through Feb 2026 stood at $155.6 million (down 9.71% YoY), and the FY2025 full-year result was $168.3 million, down 12.9% from the prior year.
• Current Assets for Q1 2026 stood at $155.6 million, down from $161.3 million in the prior quarter.
• The five-year high for Current Assets was $196.9 million in Q1 2024, with the low at $127.7 million in Q1 2022.
• Historically, Current Assets has averaged $165.3 million across 5 years, with a median of $163.5 million in 2023.
• Annual changes were most pronounced in 2024 — Current Assets advanced 29.06% — and 2025, when it fell 12.9%.
• Angiodynamics' Current Assets stood at $158.8 million in 2022, then grew by 16.77% to $185.5 million in 2023, then dropped by 5.45% to $175.4 million in 2024, then fell by 7.99% to $161.3 million in 2025, then slipped by 3.59% to $155.6 million in 2026.
• The last three Current Assets figures came in at $155.6 million (Q1 2026), $161.3 million (Q4 2025), and $156.7 million (Q3 2025), per Business Quant data.